Cleared Traditional

K900780 - CYSTICERCOSIS SEROLOGICAL REAGENTS

K900780 is an FDA 510(k) clearance for CYSTICERCOSIS SEROLOGICAL REAGENTS, manufactured by Lmd Laboratories. The device is a Class 1 Microbiology device with product code MDJ cleared through the Traditional 510(k) pathway after a 226-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
226d
Days
Class 1
Risk

K900780 is an FDA 510(k) clearance for the CYSTICERCOSIS SEROLOGICAL REAGENTS. Classified as Reagents, Cysticercosis (product code MDJ), Class I - General Controls.

Submitted by Lmd Laboratories (San Diego, US). The FDA issued a Cleared decision on October 4, 1990 after a review of 226 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3200 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Lmd Laboratories devices

FDA 510(k) Submission Details - K900780

510(k) Number K900780 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 20, 1990
Decision Date October 04, 1990
Days to Decision 226 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 102d · This submission: 226d
Pathway characteristics
Predicate-based equivalence.

MDJ Device Classification - Class 1, General Controls

Product Code MDJ Reagents, Cysticercosis
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3200
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.